/ Lupin Tanks As Unit Gets 5 USFDA Observations ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Thursday, 22 June 2017

Lupin's Pithampur Unit 3 has been issued 5 observations by the US Food and Drug Administration (USFDA), reported a national news channel.

Lupin was trading lower by 2.1% at Rs 1,071 per share at 1242 hours on BSE. It touched a high of Rs 1,089.90 and a low of Rs 1,068.25 so far during the day.

On the BSE, 1,01,867 shares traded in the counter so far. The market capitalisation of the company is Rs 48,557.75 crore.

The stock has underperformed both BSE Sensex and BSE Healthcare over a period of one year. Its closest peers include Cadila Healthcare and Sun Pharmaceutical Industries.

Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.

or Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔